140 related articles for article (PubMed ID: 37166270)
41. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
42. Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
Evangelista L; Zattoni F; Karnes RJ; Novara G; Lowe V
Nucl Med Commun; 2016 Dec; 37(12):1223-1231. PubMed ID: 27551835
[TBL] [Abstract][Full Text] [Related]
43. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
[TBL] [Abstract][Full Text] [Related]
44. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of
Fossati N; Scarcella S; Gandaglia G; Suardi N; Robesti D; Boeri L; Karnes RJ; Heidenreich A; Pfister D; Kretschmer A; Buchner A; Stief C; Battaglia A; Joniau S; Van Poppel H; Osmonov D; Juenemann KP; Shariat S; Hiester A; Nini A; Albers P; Tilki D; Graefen M; Gill IS; Mottrie A; Galosi AB; Montorsi F; Briganti A
J Urol; 2020 Aug; 204(2):296-302. PubMed ID: 32068488
[TBL] [Abstract][Full Text] [Related]
45. Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy.
Timm B; Farag M; Liodakis P; Angus D; Lim Joon D; Bolton D
BJU Int; 2021 May; 127 Suppl 1():23-29. PubMed ID: 33973332
[TBL] [Abstract][Full Text] [Related]
46. Long-term Clinical Outcomes of Repeat Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: A Case Series.
Grabbert M; Sigle A; Lang L; Büren MV; Mix M; Zamboglou C; Gratzke C; Schultze-Seemann W; Jilg CA
Eur Urol Focus; 2022 Mar; 8(2):425-430. PubMed ID: 33858813
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience.
Nyk Ł; Kamecki H; Krajewski W; Małkiewicz B; Szydełko T; Kubis M; Słojewski M; Kryst P; Poletajew S; Malewski W
Tomography; 2022 Apr; 8(2):1090-1096. PubMed ID: 35448723
[TBL] [Abstract][Full Text] [Related]
48. Role of salvage lymph node dissection in prostate cancer.
Heidenreich A; Moul JW; Shariat S; Karnes RJ
Curr Opin Urol; 2016 Nov; 26(6):581-9. PubMed ID: 27584024
[TBL] [Abstract][Full Text] [Related]
49. Salvage lymph node dissection after
Herlemann A; Kretschmer A; Buchner A; Karl A; Tritschler S; El-Malazi L; Fendler WP; Wenter V; Ilhan H; Bartenstein P; Stief CG; Gratzke C
Oncotarget; 2017 Oct; 8(48):84180-84192. PubMed ID: 29137414
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
51. Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
Montorsi F; Gandaglia G; Fossati N; Suardi N; Pultrone C; De Groote R; Dovey Z; Umari P; Gallina A; Briganti A; Mottrie A
Eur Urol; 2017 Sep; 72(3):432-438. PubMed ID: 27600589
[TBL] [Abstract][Full Text] [Related]
52. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Rogowski P; Trapp C; von Bestenbostel R; Eze C; Ganswindt U; Li M; Unterrainer M; Zacherl MJ; Ilhan H; Beyer L; Kretschmer A; Bartenstein P; Stief C; Belka C; Schmidt-Hegemann NS
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1417-1428. PubMed ID: 34628521
[TBL] [Abstract][Full Text] [Related]
53. Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
Bravi CA; Heidenreich A; Fossati N; Gandaglia G; Suardi N; Mazzone E; Stabile A; Cucchiara V; Osmonov D; Juenemann KP; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat S; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A; Pfister D
BJUI Compass; 2023 Jan; 4(1):123-129. PubMed ID: 36569505
[TBL] [Abstract][Full Text] [Related]
54. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
[TBL] [Abstract][Full Text] [Related]
55. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy.
Tilki D; Mandel P; Seeliger F; Kretschmer A; Karl A; Ergün S; Seitz M; Stief CG
J Urol; 2015 Feb; 193(2):484-90. PubMed ID: 25180792
[TBL] [Abstract][Full Text] [Related]
56. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer].
Veliev EI; Tomilov AA; Goncharuk DA; Bogdanov AB; Golubtsova EN
Urologiia; 2018 Jul; (3):105-110. PubMed ID: 30035428
[TBL] [Abstract][Full Text] [Related]
57. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
[TBL] [Abstract][Full Text] [Related]
58. Oligometastatic prostate cancer and salvage lymph node dissection: systematic review.
Brassetti A; Proietti F; Pansadoro V
Minerva Chir; 2019 Feb; 74(1):97-106. PubMed ID: 29806760
[TBL] [Abstract][Full Text] [Related]
59.
Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
[TBL] [Abstract][Full Text] [Related]
60. Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.
Maurer T; Gschwend JE; Eiber M
Curr Opin Urol; 2018 Mar; 28(2):191-196. PubMed ID: 29028767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
